Triggering Mechanisms of Post-Operative Ileus

术后肠梗阻的触发机制

基本信息

  • 批准号:
    7234092
  • 负责人:
  • 金额:
    $ 28.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-08-01 至 2009-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Postoperative ileus (POI), occurring after over 10 million abdominal surgeries per year, is so common that ileus is thought to be an accepted iatrogenic consequence and a "physiological" reaction of the bowel to operative trauma. The significance of postoperative morbidity is widely acknowledge, and its economic burden has been estimated at $1 billion per year. Three main mechanisms appear to be involved in its causation: early enhanced neurogenic activity, postoperative medications and the novel mechanism established by this laboratory - a local enteric inflammatory response. We have shown that the prolonged phase of POI ileus is caused by an enteric molecular inflammatory response that consists of: i.) activation of a dense network of muscularis macrophages, ii.) phosphorylation of transcription factors and upregulation of cytokines, chemokines and smooth muscle inhibitory substances (iNOS and COX-2), iii.) an increased expression of vascular adhesion molecules with the subsequent recruitment and extravasation of leukocytes into the circular muscle layer and the further release/secretion of various potent leukocytic products. Together these events succeed in delaying gastrointestinal transit, decrease local neuromuscular function, and activate neurogenic inhibitory pathways that suppress motility along the entire gastrointestinal tract for sustained periods. In just five years, this body of work is now acknowledged to be the principle cause of POI following abdominal surgery. These previous studies, however, have not addressed the "TRIGGER" for postoperative ileus - simply stated: what does the surgeon's hand trigger that results in the development of the inflammatory response? We now propose to investigate a dual molecular TRIGGER hypothesis for POI: 1.) physical manipulation of the intestinal wall with release of arachidonic acid resulting in inflammatory eicosanoid signaling and, 2.) physical disruption and release of extracellular matrix products (hyaluronic acid and fibronectin fragments) with subsequent CD44-mediated inflammatory signaling.
描述(由申请人提供): 术后肠梗阻(POI)发生于每年超过1000万次腹部手术后,是如此常见,以至于肠梗阻被认为是一种公认的医源性后果,是肠道对手术创伤的一种生理反应。术后并发症的重要性已被广泛认识,其经济负担估计为每年10亿美元。其原因似乎涉及三个主要机制:早期神经源性活动增强,术后药物治疗,以及本实验室建立的新机制-局部肠道炎症反应。我们已经证明,POI肠梗阻的延长是由肠道分子炎症反应引起的,它包括:i。激活致密的巨噬肌细胞网络,II。)转录因子的磷酸化和细胞因子、趋化因子和平滑肌抑制物质(iNOS和COX-2)的上调,III.)血管黏附分子的表达增加,随后白细胞重新聚集并渗入环状肌层,并进一步释放/分泌各种有效的白细胞产物。这些事件一起成功地延迟了胃肠道的传输,降低了局部神经肌肉功能,并激活了神经源性抑制通路,从而持续抑制了整个胃肠道的运动。在短短五年的时间里,这项工作现在被认为是腹部手术后POI的主要原因。然而,这些先前的研究没有解决术后肠梗阻的触发因素--简单地说:外科医生的手触发了什么导致炎症反应的发展?我们现在建议研究POI的双分子触发假说:1)物理操作肠壁,释放花生四烯酸,导致炎症性二十烷酸信号和,2。细胞外基质产物(透明质酸和纤维连接蛋白片段)的物理破坏和释放,以及随后的CD44介导的炎症信号。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANTHONY J BAUER其他文献

ANTHONY J BAUER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANTHONY J BAUER', 18)}}的其他基金

Protective Mechanisms of CO in Intestinal Inflammation
CO对肠道炎症的保护机制
  • 批准号:
    7263899
  • 财政年份:
    2005
  • 资助金额:
    $ 28.13万
  • 项目类别:
Protective Mechanisms of CO in Intestinal Inflammation
CO对肠道炎症的保护机制
  • 批准号:
    7089013
  • 财政年份:
    2005
  • 资助金额:
    $ 28.13万
  • 项目类别:
Protective Mechanisms of CO in Intestinal Inflammation
CO对肠道炎症的保护机制
  • 批准号:
    7646299
  • 财政年份:
    2005
  • 资助金额:
    $ 28.13万
  • 项目类别:
Protective Mechanisms of CO in Intestinal Inflammation
CO对肠道炎症的保护机制
  • 批准号:
    7467952
  • 财政年份:
    2005
  • 资助金额:
    $ 28.13万
  • 项目类别:
Protective Mechanisms of CO in Intestinal Inflammation
CO对肠道炎症的保护机制
  • 批准号:
    6923425
  • 财政年份:
    2005
  • 资助金额:
    $ 28.13万
  • 项目类别:
INTESTINAL INFLAMMATORY SYNERGY BETWEEN HEMORRHAGIC SHOCK AND TRAUMA
失血性休克和创伤之间的肠道炎症协同作用
  • 批准号:
    6829218
  • 财政年份:
    2004
  • 资助金额:
    $ 28.13万
  • 项目类别:
POSTOPERATIVE ILEUS INDUCED BY SURGICAL TRAUMA
手术创伤引起的术后肠梗阻
  • 批准号:
    6525470
  • 财政年份:
    1998
  • 资助金额:
    $ 28.13万
  • 项目类别:
Triggering Mechanisms of Post-Operative Ileus
术后肠梗阻的触发机制
  • 批准号:
    7077751
  • 财政年份:
    1998
  • 资助金额:
    $ 28.13万
  • 项目类别:
POSTOPERATIVE ILEUS INDUCED BY SURGICAL TRAUMA
手术创伤引起的术后肠梗阻
  • 批准号:
    6019508
  • 财政年份:
    1998
  • 资助金额:
    $ 28.13万
  • 项目类别:
Triggering Mechanisms of Post-Operative Ileus
术后肠梗阻的触发机制
  • 批准号:
    6920534
  • 财政年份:
    1998
  • 资助金额:
    $ 28.13万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 28.13万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 28.13万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.13万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.13万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 28.13万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.13万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 28.13万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 28.13万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 28.13万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.13万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了